Stay updated on Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov record describes a completed Phase 2 study evaluating copper Cu 64 PSMA I&T PET/CT imaging for recurrent metastatic prostate cancer. It includes participant criteria, study locations, outcome measures, dates, and linked study documents.SummaryDifference46%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide NIH notice announces a transition-related update and links to further information and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov footer displays an updated site revision number, from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now renders a 403 Forbidden error page with a minimal header and a Home link, replacing the previous detailed study content.SummaryDifference17%

Stay in the know with updates to Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.